The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease.

Authors:
Piccari L; Wort SJ; Meloni F; Rizzo M; Price LC and 12 more

Journal:
Respiration

Publication Year: 2022

DOI:
10.1159/000524263

PMCID:
PMC9533441

PMID:
35462365

Journal Information

Full Title: Respiration

Abbreviation: Respiration

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Statement Dr. Piccari reports grants, personal fees, and nonfinancial support from Janssen and nonfinancial support from Menarini, outside the submitted work. Dr. Wort reports grants and personal fees from Actelion UK. He has also received personal fees from MSD, Janssen, and GSK, outside the submitted work. Dr. Price reports personal fees from Janssen, outside the submitted work. Dr. Meloni, Dr. Rizzo, Dr. Martino, Dr. Salvaterra, Dr. Scelsi, Dr. López-Meseguer, Dr. Blanco, Dr. Callari, Dr. Pérez González, Dr. Tuzzolino, Dr. McCabe, Dr. Rodríguez-Chiaradía, and Dr. Vitulo, have nothing to disclose."

Evidence found in paper:

"Dr. Piccari has received a PVRI Fellowship (grant no. RGLP003) for the SUPPORT project, which partly supported the present work; the PVRI was not involved in the design or the completion of this study. No other funding was obtained for this study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025